As the novel coronavirus (COVID-19) ravages the healthcare industry and the world, medical device companies with products used in elective procedures have taken a huge hit. The good news is, as healthcare systems begin again to expand beyond emergency and urgent cases, pent-up demand will exist for elective procedures.
Learn how a strategic framework can help you assess which procedures will take priority.